Skip to main content

Peer Review reports

From: First-line single-agent panitumumab in frail elderly patients with wild-type RAS unresectable colorectal cancer: a phase II study protocol OGSG 1602

Original Submission
15 Dec 2017 Submitted Original manuscript
2 Mar 2018 Author responded Author comments - tetsuji terasawa
Resubmission - Version 2
2 Mar 2018 Submitted Manuscript version 2
20 Jul 2018 Reviewed Reviewer Report - Teresa Macarulla
23 Dec 2018 Reviewed Reviewer Report - John Souglakos
20 Feb 2019 Reviewed Reviewer Report - Roberto Moretto
24 Apr 2019 Author responded Author comments - tetsuji terasawa
Resubmission - Version 3
24 Apr 2019 Submitted Manuscript version 3
31 May 2019 Author responded Author comments - tetsuji terasawa
Resubmission - Version 4
31 May 2019 Submitted Manuscript version 4
Publishing
11 Jun 2019 Editorially accepted
25 Jun 2019 Article published 10.1186/s12885-019-5821-z

You can find further information about peer review here.

Back to article page